Accuracy of a reverse dot blot hybridization assay for simultaneous detection of the resistance of four anti-tuberculosis drugs in Mycobacterium tuberculosis isolated from China
Infectious Diseases of Poverty·
- DOI
- 10.1186/s40249-020-00652-z
- PMID
- —
- PMCID
- —
- OpenAlex
- W3016443054
- Study type
- Journal article
- Publisher
- Springer Science and Business Media LLC
- Article type
- journal-article
- Integrity
- current
Why this research matters now
Timely identification of antimicrobial resistance profiles may support faster clinical decision-making for tuberculosis management in endemic regions.
Structured evidence summary
Research question
What is the diagnostic accuracy of a reverse dot blot hybridization method for identifying resistance to rifampicin, isoniazid, streptomycin, and ethambutol in Chinese Mycobacterium tuberculosis isolates?
Study design
Laboratory-based diagnostic accuracy study comparing a molecular hybridization technique against phenotypic susceptibility testing and genetic sequencing across three hundred twenty clinical isolates.
Population and setting
Clinical Mycobacterium tuberculosis specimens collected from patients within China.
Main findings
The molecular assay demonstrated high agreement with reference methods, showing concordance rates ranging from seventy-seven percent to ninety-eight percent depending on the comparator and drug tested. Performance metrics indicated strong sensitivity and specificity values, particularly for rifampicin and isoniazid, while ethambutol showed lower sensitivity relative to phenotypic testing. The platform processed forty-two specimens simultaneously within seven hours.
Public-health relevance
Timely identification of antimicrobial resistance profiles may support faster clinical decision-making for tuberculosis management in endemic regions.
Important limitations
The evaluation relied exclusively on clinical isolates from a single geographic region, which may restrict generalizability to other populations. Additionally, performance metrics varied notably across different drug targets, with reduced sensitivity observed for ethambutol detection compared to phenotypic standards.
GIDS interpretation
This publication provides foundational diagnostic validation data that could inform future laboratory network standardization efforts or guide the development of molecular screening protocols for tuberculosis control programs.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 9 auditable classifier relationships to diseases, places, topics, and study design.